Alnylam Pharmaceuticals Inc (NASDAQ:ALNY)

125.40
Delayed Data
As of May 26
 -1.35 / -1.07%
Today’s Change
117.58
Today|||52-Week Range
212.00
-26.05%
Year-to-Date

Stock Price Forecast

The 21 analysts offering 12-month price forecasts for Alnylam Pharmaceuticals Inc have a median target of 205.00, with a high estimate of 430.00 and a low estimate of 96.00. The median estimate represents a +63.48% increase from the last price of 125.40.

Analyst Recommendations

The current consensus among 23 polled investment analysts is to Buy stock in Alnylam Pharmaceuticals Inc. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$1.61
Sales
$256.4M
Reporting Date
Aug 10

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 19.64%
 
 
 
 
 
 
Growthannually 7.61%
 
 
 
 
 
 

Sales

Growthquarterly 20.22%
 
 
 
 
 
 
Growthannually 28.89%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.